companydata.dkEUSA Pharma (Denmark) ApS: Financial statements 2022
CVR: 39055988
EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 3,037,780 and a net result of DKK 198,473 compared with DKK 482,679 the year before. That is a decrease of 67.8% compared with the year before. Equity amounted to DKK 1,503,728. The solvency ratio was 74.7%. The company had 2 employees in the financial year.
- Gross Profit
- 3,037,780 kr.
- Profit/Loss
- 198,473 kr.
- Equity
- 1,503,728 kr.
- Total Assets
- 2,013,718 kr.
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 3 mio. | 198 t. | 1.5 mio. | 2 |
| 2021 | - | 9.4 mio. | 483 t. | 1.3 mio. | 5 |
| 2020 | - | 9.8 mio. | 607 t. | 823 t. | 6 |
| 2019 | - | 2.1 mio. | 228 t. | 215 t. | 3 |
Keep an eye on EUSA Pharma (Denmark) ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of October 13, 2022, Joakim Karl Viktor Åberg is registered as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Francesco Palombi is registered as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Emma Jane Johnson has stepped down as director of EUSA Pharma (Denmark) ApS.
As of October 13, 2022, Dev Kumar has stepped down as director of EUSA Pharma (Denmark) ApS.
EUSA Pharma (Denmark) ApS has published its annual report for 2021. Gross profit came to DKK 9,429,497, and the net result was DKK 482,679.
As of March 16, 2022, Luigi Longinotti is registered as director of EUSA Pharma (Denmark) ApS.
As of March 16, 2022, Frank Carsten Thiel has stepped down as director of EUSA Pharma (Denmark) ApS.
About EUSA Pharma (Denmark) ApS
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017 and dissolved in 2024. The company was registered under the industry Reklamebureauer. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity amounted to DKK 1,644,740.